biosimilarscouncil.org | Home | Biosimilars Council

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
Sitemap: https://www.biosimilarscouncil.org/page-sitemap.xml Sitemap: https://www.biosimilarscouncil.org/resource-sitemap.xml Sitemap: https://www.biosimilarscouncil.org/team-sitemap.xml Sitemap: https://www.biosimilarscouncil.org/category-sitemap.xml Sitemap: https://www.biosimilarscouncil.org/post_tag-sitemap.xml Sitemap: https://www.biosimilarscouncil.org/author-sitemap.xml User-agent: * Disallow: /wp-admin/ Allow:

Meta Tags

Title	Home \| Biosimilars Council \| Leading Resource on
Description	Biosimilars are a prescription for better The Biosimilars Council, a division of the Association for Accessible Medicines, works to ensure a positive future for biosimilar
Keywords	N/A

Server Information

WebSite	biosimilarscouncil.org
Host IP	141.193.213.20
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

biosimilarscouncil.org Valuation

US$4,311,211

Last updated: 2023-05-14 00:02:11

biosimilarscouncil.org has Semrush global rank of 2,455,065. biosimilarscouncil.org has an estimated worth of US$ 4,311,211, based on its estimated Ads revenue. biosimilarscouncil.org receives approximately 497,448 unique visitors each day. Its web server is located in United States, with IP address 141.193.213.20. According to SiteAdvisor, biosimilarscouncil.org is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$4,311,211
Daily Ads Revenue	US$3,980
Monthly Ads Revenue	US$119,388
Yearly Ads Revenue	US$1,432,649
Daily Unique Visitors	33,164
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
biosimilarscouncil.org.	A	299	IP: 141.193.213.20
biosimilarscouncil.org.	A	299	IP: 141.193.213.21
biosimilarscouncil.org.	NS	86400	NS Record: jake.ns.cloudflare.com.
biosimilarscouncil.org.	NS	86400	NS Record: mimi.ns.cloudflare.com.
biosimilarscouncil.org.	MX	300	MX Record: 0 biosimilarscouncil-org.mail.protection.outlook.com.
biosimilarscouncil.org.	TXT	300	TXT Record: google-site-verification=9E7DQbipNkdn2xS3lRokABmpvB1dAOhNs_AWYwYXmEE
biosimilarscouncil.org.	TXT	300	TXT Record: google-site-verification=vMOzOrzdaHm7myoY0ENQeQMT4N3l2lRPJ--9sb-3QLg
biosimilarscouncil.org.	TXT	300	TXT Record: MS=ms57174544
biosimilarscouncil.org.	TXT	300	TXT Record: ca3-a0bacf2e293946da8fcfef097f8a801e
biosimilarscouncil.org.	TXT	300	TXT Record: ca3-b340ae75b9d8453abddb58345fc50ea7
biosimilarscouncil.org.	TXT	300	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-14 00:02:11

Take Action More results... Generic selectors Exact matches only Search in title Search in content Post Type Selectors Filter by Categories Backgrounder Biosimilars Bulletin Blog Council Resource Event Handbook Infographic Issue Brief Media Member Spotlight Partner Resource Policy Recommendation Press Release Report Statement Video Whitepapers LinkedIn Twitter Facebook YouTube About Advocacy Events Resources All Resources For Patients Biosimilars Handbook Research and Studies 2022 Savings Report Reports & White Papers Blog In the News Press Releases FDA-Approved Biosimilars Biosimilars are a prescription for better health. In the U.S., Biosimilars could lead to over $130 billion is savings by 2025, and have been used in over 364 million days of patient therapy. Learn More Register Now! GRx+Biosims 2023 GRx+Biosims™ 2023, the premier regulatory science and policy event for the U.S. generics and biosimilars industry, will be held on October 2-4 in North Bethesda, Maryland! Get the

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 22 Dec 2021 09:31:20 GMT
Content-Type: text/html
Connection: keep-alive
Location: https://biosimilarscouncil.org/
CF-Cache-Status: DYNAMIC
Server: cloudflare
CF-RAY: 6c18562f2eb0f019-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Wed, 22 Dec 2021 09:31:21 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
vary: X-NR-SAMPLE-PERCENT
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-pass-why: custom-path
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare
cf-ray: 6c18562fa8d58cae-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

biosimilarscouncil.org Whois Information

Domain Name: BIOSIMILARSCOUNCIL.ORG
Registry Domain ID: D176003495-LROR
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.whois.godaddy.com
Updated Date: 2021-04-15T12:36:05Z
Creation Date: 2015-04-14T15:30:37Z
Registry Expiry Date: 2022-04-14T15:30:37Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: +1.4806242505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registrant Organization: Domains By Proxy, LLC
Registrant State/Province: Arizona
Registrant Country: US
Name Server: JAKE.NS.CLOUDFLARE.COM
Name Server: MIMI.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form https://www.icann.org/wicf/)
>>> Last update of WHOIS database: 2021-12-25T21:34:26Z <<<

biosimilarscouncil.org valuation and analysis